Risk of systemic reactions during pediatric allergen-specific immunotherapy: clinical predictors and safety outcomes
Turkish Journal of Medical Sciences · 13.08.2026 · 56 (4) · 1031-1039
DOI: 10.55730/1300-0144.6347 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 13.08.2026. Verfasst von Figen Çelebi Çelik und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Allergy and Immunology, Department of Pediatrics, Dr. Behcet Uz Pediatric Diseases and Surgery Training and Research Hospital, …. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Asthma, Rhinitis, Allergic, Allergens. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: This study aimed to evaluate the frequency, timing, severity, and clinical predictors of systemic reactions in children receiving subcutaneous allergen-specific immunotherapy (SCIT) with house dust mite (HDM) and grass pollen extracts under real-world clinical conditions. Materials and methods: This multicenter retrospective study included 623 children with moderate-to-severe allergic rhinitis, with or without asthma, who received SCIT between 2006 and 2023 at two tertiary pediatric allergy centers. Clinical characteristics, laboratory findings, immunotherapy protocols, and systemic reactions (SRs) were recorded and graded according to the updated 2024 World Allergy Organization (WAO) systemic reaction scale.
Results
SCIT was well tolerated. Systemic reactions occurred in 10.7%, corresponding to 0.27% per injection. Most SRs were mild-to-moderate (WAO grades 1–2), and approximately three-quarters occurred during the maintenance phase. A progressive decline in SR incidence was observed throughout the treatment period. In the pollen SCIT subgroup, asthma was the only independent predictor of SRs (OR, 2.35; 95% CI 1.13–4.88; p = 0.022). No life-threatening reactions or fatalities were observed.
Conclusion
Pediatric SCIT with pollen and HDM extracts demonstrated a favorable safety profile, with infrequent and predominantly nonsevere systemic reactions. The association between asthma and SRs in pollen SCIT highlights the importance of optimal asthma control throughout immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Allergy and Immunology, Department of Pediatrics, Dr. Behcet Uz Pediatric Diseases and Surgery Training and Research Hospital, İzmir Faculty of Medicine, University of Health Sciences, İzmir, Turki…
- Division of Pediatric Allergy, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.
ORCID-Profile: Figen Çelebi Çelik, Alp Kazancioğlu, Soner Günder, Melike Ocak, Berna Uzunoğlu, Canan Şule Karkiner, Özlem Sancakli, Ayfer Tuncer, Özge Uysal Soyer, Bülent Enis Şekerel, Demet Can, Ümit Murat Şahiner
Zitieren
APA
Çelebi Çelik, F., Kazancioğlu, A., Günder, S., Ocak, M., Uzunoğlu, B., Karkiner, C. Ş., Sancakli, Ö., Tuncer, A., Uysal Soyer, Ö., Şekerel, B. E., Can, D., & Şahiner, Ü. M. (2026). Risk of systemic reactions during pediatric allergen-specific immunotherapy: clinical predictors and safety outcomes . Turkish Journal of Medical Sciences, 56(4), 1031-1039. https://doi.org/10.55730/1300-0144.6347
Vancouver
Çelebi Çelik F, Kazancioğlu A, Günder S, Ocak M, Uzunoğlu B, Karkiner CŞ, et al. Risk of systemic reactions during pediatric allergen-specific immunotherapy: clinical predictors and safety outcomes . Turkish Journal of Medical Sciences. 2026;56(4):1031-1039. doi:10.55730/1300-0144.6347
BibTeX
@article{elebielik2026,
author = {Çelebi Çelik, Figen and Kazancioğlu, Alp and Günder, Soner and Ocak, Melike and Uzunoğlu, Berna and Karkiner, Canan Şule and Sancakli, Özlem and Tuncer, Ayfer and Uysal Soyer, Özge and Şekerel, Bülent Enis and Can, Demet and Şahiner, Ümit Murat},
title = {Risk of systemic reactions during pediatric allergen-specific immunotherapy: clinical predictors and safety outcomes },
journal = {Turkish Journal of Medical Sciences},
year = {2026},
volume = {56},
number = {4},
pages = {1031--1039},
doi = {10.55730/1300-0144.6347}
}
EUVIMED